Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Kartheek Dokka is a product management professional with experience in digital transformation and technical innovation. His ...

Infosys recently laid off 240 trainees due to their failure to meet internal assessment criteria, offering them transition ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

An exclusive Inside Climate News analysis found that a single year of greenhouse gas emissions from tankers carrying LNG from ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Analysis-Pharma Companies Expected to Absorb Any Tariff ... Societe Generale estimated that U.S. tariffs could add $46 ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, and nuclear research, where controlled environments are essential. Rising ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

Stelara, a treatment for psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease, is Johnson & Johnson’s most high-profile case. In 2024 alone, it generated $6.72 billion in U ...

Through a detailed examination of Microsoft, we can deduce the following trends: With a Price to Earnings ratio of 31.47, which is 0.42x less than the industry average, the stock shows potential ...